FTSE 100 ends higher as BT declares Openreach plans, US jobs gain
FTSE 100 stocks ended higher on Friday, led by telecoms behemoth BT after confirming it would separate Openreach
Company
Synairgen PLC
LON:SNG
Synairgen PLC is a UK-based respiratory company focused on drug discovery and the development of SNG001 (inhaled interferon beta) as potentially the first host-targeted, broad-spectrum antiviral treatment delivered directly into the lungs for severe viral lung infections.
149 stories · page 8 of 8
Proactive news summary – Mirada, Tissue Regenix, Synairgen and Vast Resources
A selection of the day's significant news stories from the junior AIM market
Risers & Fallers: Petrel rallies on work application in Ghana
Largest share price rises and falls in London at 4.00pm
AstraZeneca likely to adapt clinical trial of Synairgen drug
Hard-to-treat cases of asthma, known as severe exacerbations, tend to be caused by the common cold and flu. Unexpectedly, colds did not cause as many of these exacerbations as researchers predicted.
High profile financier Leonard Licht invests in Synairgen
Now a private investor, Leonard Licht has acquired 2.775mln shares or 3.04%.
Synairgen PLC and why the market is not the best arbiter of value
If the market worked as perfectly as its more rabid advocates insist, we wouldn’t have attractive anomalies such as Synairgen..
Synairgen makes progress with lung drug
Lung drug developer says tests showed success in treating idiopathic pulmonary fibrosis
Investments and investor services
Risers & Fallers: Motive Television, XLMedia, ECR Minerals, Kimberly Enterprises, Spire, Halfords
Below are the main news-driven share price movements at 4pm.
Risers & Fallers: SABMiller, Styles & Wood, Dillistone, Cello Group, Synairgen and Quadrise Fuels
Below are the main news-driven share price movements at 12.30pm.